Behavioral deficits following exposure to different neurotoxicants during development may be manifested as a delay in onset of a behavior, a regression of a previously articulated behavior to performance seen earlier in development (before the normal onset or development of the behavior), or intrusions of unusual or aberrant behaviors which replace those behaviors normally seen at developmental time points. These behavioral deficits, which are all seen in clinical cases of children with autism or pervasive developmental disorders, may be the result of late postnatal or early neonatal exposure to neurotoxicants.
The aims of the current research project include a) characterize normal development of behaviors related to cerebella, striatal and hippocampal development through behavioral testing and changes in cell adhesion molecules (CAMs); b) administer methylmercury and sodium valproate to animals just prior or just following the normal ontogeny of these behaviors in order to determine critical periods of brain development which these compounds affect; c) link normal and aberrant development of these behaviors to regional changes neurochemistry as well as alterations in CAM levels and CAM mRNA in discrete brain areas, as well as assessing the neurotoxic potential of these compounds using an assay which is independent from changes in cell adhesion proteins d) assess sensitivity of treated animals to later challenge with agents which may potentially exacerbate deficits, produce intrusions in behavior, or alleviate functional deficits and reverse altered cell adhesion molecule expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32ES011729-01
Application #
6486509
Study Section
Special Emphasis Panel (ZRG1-F10 (20))
Program Officer
Shreffler, Carol K
Project Start
2002-07-01
Project End
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
1
Fiscal Year
2002
Total Cost
$44,212
Indirect Cost
Name
Rutgers University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
038633251
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Halladay, A K; Wagner, G C; Sekowski, A et al. (2006) Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan. Synapse 59:277-89
Halladay, A K; Wilson, D T; Wagner, G C et al. (2006) Trimethyltin-induced alterations in behavior are linked to changes in PSA-NCAM expression. Neurotoxicology 27:137-46
Halladay, A K; Tessarollo, L; Zhou, R et al. (2004) Neurochemical and behavioral deficits consequent to expression of a dominant negative EphA5 receptor. Brain Res Mol Brain Res 123:104-11
Halladay, Alycia K; Kusnecov, Alexander; Michna, Lauri et al. (2003) Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice. Pharmacol Toxicol 93:33-41